Tissue engineering has been focused on the fabrication of vascularized 3D tissue for decades. Most recently, bioprinting, especially tissue and organ printing, has shown great potential to enable automated robotic-based fabrication of 3D vascularized tissues and organs that are readily available for in vitro studies or in vivo transplantation. Studies have demonstrated the feasibility of the tissue printing process through bioprinting of scaffold-free cellular constructs that are able to undergo self-assembly for tissue formation; however, they are still limited in size and thickness due to the lack of a vascular network. In this paper, we present a framework concept for bioprinting 3D large-scale tissues with a perfusable vascular system in vitro to preserve cell viability and tissue maturation. With the help of a customized Multi-Arm Bioprinter (MABP), we lay out a hybrid bioprinting system to fabricate scale-up tissues and organ models and demonstrated envision its promising application for in vitro tissue engineering and its potential for therapeutic purposes with our proof of concept study.
Introduction
Tissue engineering has shifted the paradigm of traditional medicine from therapeutically treating disease to replacing diseased tissues and organ parts by regenerative medicine approaches. This remarkable leap in medical science has drawn great attention for decades and has brought tremendous opportunities to not only disease treatment, but also drug testing, disease modeling, and other physiological and pathological research [1] .
Traditional tissue engineering has had great success in artificial tissue or organ fabrication by advancement of stem cell technology, materials science, and biomimetic system design. Ever since Robert Langer grew an ear on a mouse back by seeding cells onto a biopolymer scaffold, this technology has enabled bioengineered tissue such as cartilage, bone, skin, etc., to be grown in laboratories around the world [2] . These successes were largely limited to tissues with avascular nature, which have lower oxygen consuming rates. However, a long-term obstacle for tissue engineering has been generation of vascularized tissue with blood perfusion capability, which is critical for organogenesis, especially in vivo [3] . Traditional scaffolding methods often fail to provide an efficient media (oxygen, growth factor, water, etc.) transportation system for generation of thick tissues or organs. Several researchers have attempted to control scaffold architecture to mediate media transport capabilities [4] , but the majority have failed in organ or tissue formation due to the lack of an integrated vascular system [5] . One possible solution to improve perfusion through thick scaffolds is embedded microfluidic networks; however, most of the microfluidic fabrication methods are multistep processes that do not allow direct fabrication of a vessel-like structure for tissue integration [6] .
Organ printing can be defined as layer-by-layer additive robotic fabrication of three-dimensional (3D) functional living tissues or organs. It has been envisioned to push tissue engineering into a new era with the capability to do robotic large-scale living organ fabrication [7] . It was inspired by the natural embryonic developmental process and used cell aggregates in a microspherical shape as building blocks with a rapid-prototyping platform. These "mini-tissues" have certain measurable and controllable properties and can be assembled into macrotissues through the tissue fusion process or directed tissue self-assembly. With this method, scientists used multicellular spheroids made from smooth muscle cells and fibroblasts to successfully generate vascular constructs [8] . It was predicted that this robotic-assisted biomimetic process would be dramatically beneficial for tissue engineering in the near future [9] . In order to integrate a vasculature network within the tissue printing process, the vasculature network should be practically printed without requiring any support material; it also needs to be printed in complex geometries on a larger scale to feed the oxygenation need of larger tissues.
Cell aggregates possess accelerated fusion and folding capabilities upon contacting each other that is driven by a natural biological process [10] . High cell density within aggregates can be easily obtained by the fusion process, in which traditional scaffolding and cell-laden hydrogel usually depend on cell proliferation afterward. Moreover, cell viability is enhanced due to the large cellseeding density and reduced mechanical stress experienced compared with direct cell manipulation. Microscale organoids, in which heterocellular aggregates possess organ-like functions, have been generated in vitro for pancreatic, liver, and cartilage tissues [11] [12] [13] . Although these techniques seem to be impressive for tissue engineering, especially as bio-ink for organ printing, their labor-intensive fabrication in limited scale makes their applicability for large-scale tissue/organ fabrication difficult. Moreover, printing them sequentially by ensuring contact between each adjacent spheroid is another hurdle, given the extremely critical handling and sterilization conditions. Without ensuring seamless contact in microscale resolution, spheroids can hardly fuse with each other, easily leaving gaps and openings in the tissue as discussed in our recent review paper [3] . Besides, hydrogels are required as a transferring medium to deposit spheroids; this may not achieve complete scaffold-free fabrication and may face side effects of biomaterial degradation. In addition, technologies should be developed to prevent spheroid fusion before printing; otherwise, nozzle clogging is inevitable. New technologies need to be developed to enable scalable, standardized spheroid fabrication to allow large-scale automated tissue fabrication as well as minimize cell damage both transcriptionally and functionally. In terms of tissue maturation, the cellular fusion process needs to be well characterized to understand cell interactions under various mechanical and biological cues. Cellular reaction upon fusion also needs to be addressed to elaborate on how extracellular matrix (ECM) is secreted by cells, and how to control ECM production as well as remodeling to ensure the mechanical integrity and strength of the regenerated tissues or organs. The most challenging issue currently faced in organ printing technology is the generation of a "built-in" vascular system within 3D thick tissues or organs with perfusion capability [10] . An integrated bioreactor is also in demand upon establishing a perfusable vascular network for continuously supplying oxygen and nutrients sufficient for cell growth and tissue maturation.
Our goal in this paper is to present a novel conceptual blueprint for a large-scale vascularized tissue printing process via a hybrid fabrication approach, which allows a vascular system and tissue to be printed in tandem. We introduce a new biomimetic design approach to develop perfusable tissues using a biologically driven fusion, folding, and maturation process. Large-scale hybrid tissues can be fabricated by the integration of a vasculature network in multiscale with tissue-specific cell aggregate strands, which are considered tissue strands, followed by rapid fusion, remodeling, and maturation of the perfusable tissues. Geometric modeling for hybrid tissue construct fabrication is performed, and future directions for tissue printing are also discussed.
Hybrid Fabrication of 3D Perfusable Tissues
In order to fabricate viable, functional tissues and organ counterparts in 3D, the integration of a vascular network is the foremost component that needs to be taken care of. Without vascularization, engineered 3D thick tissues or organs cannot get enough nutrients, gas exchange, and waste removal, all of which are needed for maturation during perfusion [14] . This results in low cell viability and malfunction of artificial tissues. Systems must be developed to transport nutrients, growth factors, and oxygen to cells while extracting metabolic waste products such as lactic acid, carbon dioxide, and hydrogen ions so the cells can grow and fuse together, forming the tissues. Cells in a large 3D tissue construct cannot maintain their metabolic functions without vascularization, which is traditionally provided by blood vessels [15] . A vascular network is indeed a very complex hierarchy, where large-scale arteries and veins are connected by a complex microscale capillary system, where media exchange takes places between the blood and the tissue. Every single cell is supplied by capillaries for its normal metabolism, in order to stay viable and be able to proliferate for maintaining tissue integrity and function. Bioprinting technology, on the other hand, currently does not allow multiscale tissue fabrication, where bifurcated vessels are required to be manufactured with capillaries to mimic natural vascular anatomy. Although several researchers have investigated developing vascular trees using computer models [16] , only a few attempts have been made toward fabricating bifurcated or branched channels [17] . Successful maturation toward functional mechanically integrated bifurcated blood vessel network is still a challenge. Thus, we introduce a novel concept to fabricate a vascular network within the hybrid tissue, which can be performed in two steps: (1) bioprinting of a macroscale vasculature network in tandem with vascularized tissue strands and (2) biologically driven tissue fusion and assembly with envisioned capillary sprouting from macrovasculature to the tissue. The former presents more of a bioprinting approach than the latter, which is mainly biologically mediated.
2.1 Design for Hybrid Bioprinting Approach. In this paper, we introduce a new hybrid bioprinting approach to fabricate perfusable tissues in 3D. It combines vasculature printing and tissuespecific cell aggregate strand printing in a single platform. Figure  1 illustrates the concept for a scale-up tissue printing, where two units of the bioprinter can run in tandem, printing two distinct materials. Strands are made of purely cells and their ECM, and they will be used as building blocks to construct the scale-up organ due to their quick fusion, folding, and maturation capabilities. In this concept, a printable vascular network in a continuous single luminal form in macroscale would be more practical to be integrated with additive manufacturing-based bioprinting. In this way, semipermeable vasculature can be printed continuously with a predetermined 0 deg/90 deg lay-down pattern similar to the traditional additive manufacturing techniques. In order to eliminate blockage of vasculatures, arc fitting is used at U-turns between two vasculatures during zigzag printing. Upon fabrication, oxygenized media can be perfused through the macrovascular network and diffused out to the tissue strands to keep them viable. In order to print the scale-up hybrid model, the MABP developed in our recent work [18] can be used. The MABP (see Fig. 2 (a)) facilitates synchronization and co-ordination between multiple arms through a sensor-based system that enables crosstalk between multiple arms so that two arms can communicate in an intelligent way, ensuring collision-free motion. One arm is equipped with a coaxial nozzle assembly for printing the vascular network, and the other arm is equipped with a custom unit to print tissue-specific cell aggregate strands (see Figs. 2(b)-2(d)). The nozzle configuration enables close motion of printer units. The introduced MABP has the potential to reduce the fabrication time, which is crucial for scale-up technologies, and would enable continuous deposition, which yields more consistent results since material deposition during starts and stops is not as uniform as it is during the rest of the process. Continuous deposition also alleviates nozzle clogging since it generally occurs when the material is in static conditions. Most importantly, nozzle motions have more flexibility in z-axis, which is critical while printing vasculature with variational dimensions that necessitate instantaneous changes between the nozzle tip and the printing stage to eliminate blockage of the Fig. 1 Concept of 3D tissue-printing technology: vascular network is printed in tandem with tissue-specific aggregate strands to provide both mechanical support and media perfusion lumen, which is quite difficult to achieve with a traditional singlearm bioprinter.
Direct Bioprinting of Macrovasculature Network.
The vasculature network in the proposed hybrid bioprinting concept can be directly printed using a pressure-assisted coaxial nozzle unit demonstrated in Fig. 2 (c). Biomaterials such as sodium alginate, collagen, and chitosan or their composites encapsulating different cell types existing in natural blood vessels such as smooth muscle, fibroblasts, and endothelial cells can be printed without any support materials that make them practical for further applications. With continuous flow chemical crosslinker through the core section of the coaxial nozzle, vasculatures can be printed directly. Fabrication of vasculature with controllable dimensions in the micro-and sub-millimeter-scale is quite feasible as presented in our recent work [19] . Figure 3 shows examples of fabricated vasculatures using 4% (w/v) sodium alginate crosslinked with 4% calcium chloride (CaCl 2 ) solution. The sodium alginate dispensing pressure was set at 21 kPa, and the CaCl 2 dispensing rate was set at 16 ml/min. The printing speed of the robot arm was set at 14 mm/s. Second passage of human umbilical vein smooth muscle cells was encapsulated with a density of 10 Â 10 6 cells/ml, where further culture was provided under pulsatile flow mimicking a hemodynamically equivalent environment. Geometrically welldefined vasculatures can be manufactured at any geometry, length, and orientation, without occlusion or rupture that might result in leakage or burst (see Fig. 3(b) ). In addition, they are highly permeable, which enables diffusion of media in the radial direction upon perfusion with a pumping system, which is similar to natural blood vessels. In our recent studies, we reached an 8.2 6 0.3 lL/ min filtration rate within 3 h of perfusion [20] . Although they have acceptable mechanical properties to sustain both tensile and compressive forces with reasonable matrix deposition in a short period of time (see Fig. 3(c) ), further enhancement will be helpful to improve their strength through exogenous collagen and elastin fibers generated by methods such as electrospinning. Vasculatures, in general, are able to support printed tissue strands, which usually do not have sufficient mechanical strength and integrity alone to build 3D tissue. Vasculatures are printed into a highly organized 3D framework for tissue strands to attach on, providing an initial microenvironment in which they can develop and ultimately fuse to each other. In addition, previous studies have demonstrated the capability of the bioprinting system to fabricate vasculature with controllable dimensions in the micro-and submillimeter-scale by altering process parameters [20] , which gives substantial flexibility to the process. In other words, differentsized vasculatures can be printed to fit specific functional needs.
Bioprinting and Biofabrication of Vascularized Tissue
Strands. This section demonstrates tissue strands that can be used as building blocks for the scale-up tissue printing process. In general, tissue strands can be generated by monoculturing or coculturing cells including endothelial cells for capillary formation using microfluidics-or molding-based fabrication approaches. Aggregation of cells takes 1-2 weeks, depending on the applied fabrication technique as well as the type and size of cells used in the study. Harvested cells need to be mixed and aggregated at a predetermined optimal ratio for in vitro angiogenesis. Tissue strands can be fabricated in any length; however, the diameter is limited to the applied aggreation technique as well as diffusion limit of oxygen (see Fig. 4(a) ). The greater the diameter, the lower the cell viabily in the inner sections of the tissue strands, although neovascularization is also achieved. The tissue strands are then loaded into the bioprinter unit using custom tools and directly printed with the vasculature network layer by layer predetermined by the toolpath plan generated by a computer-aided design model.
Our studies have shown that aggregated tissue strands present high viability and rapid fusion capabilities. In this paper, we used 2 Â 10 8 fibroblast cells and the average cell viability on day 1 postfabrication was 75 6 0.5%, which gradually increased to 77 6 0.5%, and finally reached to 87 6 3% on day [11, 21, 22] . A similar phenomenon can be envisioned for tissue strands as well if appropriated culture conditions are followed. This scaffold-free approach provides a practical approach in printing larger constructs. It enables printing tissue aggregates continuously, which prevents gaps and breakage in the printed construct.
Geometric Modeling of Hybrid Constructs.
In this section, the proposed design is mathematically represented in order to fulfill fabrication and postfabrication requirements, which can be used to determine design variables for bioprinting. As can be seen in Fig. 5 , arc fitting is used at U-turns between two consecutive vasculatures during zigzag printing, which eliminates Transactions of the ASME occlusion of vasculatures. The first and the last vasculatures in each layer should be printed longer than the tissue strands and other vasculatures in order to connect the construct to the perfusion system easily. During hybrid bioprinting, it is not practical if the tissue strand diameter is relatively smaller than that of vasculatures, while tissue strands fuse to each other during in vitro culture and contracts in some extent. Using smaller diameter tissue strands thus bring several issues such as longer fabrication time, less structural integrity, and formation of gaps in the tissue when folding takes place. Tissue strands cannot be greater than the vasculature in diameter as well, otherwise, clearance can be generated between the tissue and vasculature, which results in media accumulation in the clearance during perfusion. Thus, the diameter of the tissue strand should be same as that of the vasculature, which can be adjusted before or during bioprinting process. For a square layer as shown in Fig. 5 , the diameter of the vasculature and tissue strands is equal and denoted by D (lm). In addition to relative size of diameters, the number of tissue strands between two contiguous vasculatures is also important due to media diffusion requirement. Concentrations of solutes such as nutrients and oxygen around vasculatures change gradually. In order to provide an efficient media transportation system, the variation of solute concentration gradients around vasculatures should be minimized, which can be achieved by designing distance between consecutive vasculatures. The distance between two contiguous vasculatures at which the nutrients diffuse to based on cellular consumption of nutrients is called the Krogh length
, where D s (lm 2 /s), R C (mol/ls), and c o are diffusion constant of the concerning solute in the tissue strands, consumption rate of the solute by cells, and concentration of the solute in the vasculature, respectively. The number of tissue strands between two contiguous vasculatures (n) can be thus calculated as
where n has to be an integer. In order to maximize the consumption of the concerning solute, n should be the largest integer equal to or smaller than the right side of Eq. (1). In addition, the curvature of U-turn can be easily calculated based on the number of tissue strands and their diameter. The fabrication of tissue strand is highly expensive and time consuming. It may take a month or more to expand significantly high number of cells to be used in tissue strand fabrication. On the other hand, preparation of materials for vasculature printing is negligibly cheap. In order to make the tissue printing process practical and make the best use of the material, it is essential to calculate the volume of cell aggregates before printing them. If the number of straight vasculatures is n c , the width W (lm) of the square construct can be calculated as
, which can be reorganized as
The total volume of cell aggregates V total (lm 3 ) needed for tissue strand printing for each layer can be then calculated as follows: for n ¼ 2m
Subject to :
The reader is referred to the Appendix for derivation of above equations. With mathematical formulations presented in this section, the operator can eliminate the risk of tissue death due to lack of oxygen or vital nutrients and make the tissue printing process practical and maximize the utilization of cell aggregates, which is one of the challenges in this process.
Envisioned Biologically Driven Capillary Sprouting: Bridging Capillaries and Main Vasculatures.
Like all other tissue engineering techniques, generation of a functional tissue or organ with an internal vascular network is an ultimate goal. To successfully create vascularization in multiscale within the introduced hybrid tissue concept, a fabricated hybrid constructs need to be placed in a custom-made perfusion chamber, which is then connected to a circulating tubing system to facilitate continuous supply of the cell culture media in vitro (see Fig. 6 ). The perfusion chamber serves as a bioreactor to not only ensure sufficient support for hybrid tissue, but also to provide an environment similar to in vivo condition. The connecting tubing needs to be precisely inserted into the inlet and outlet of vasculatures using a micropositioning system. Upon positioning the whole perfusion system into an incubator, oxygenized cell culture media are delivered through the system using multichannel peristaltic pumps. The media in the reservoir need to be replenished at a regular base after culturing. Growth factors such as fibroblast growth factor and epidermal growth factor, which are essential for angiogenesis, are supplemented within the circulating culture media. The printed tissue strands fuse to each other in 3D, creating a larger tissue enclosing the vasculature during in vitro incubation in a customized bioreactor with continuous media perfusion. More importantly, upon the formation of a 3D tissue construct, the abovementioned angiogenesis growth factors are applied for further in vitro culturing to
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DECEMBER 2014, Vol. 136 / 061013-5 drive the natural process of vascularization between the main vasculature and prevascularized tissue strands, creating sprouting. Ultimately, a thick 3D tissue construct can be fabricated with a biomimetic vasculature system and be readily available for transplantation, disease modeling, or drug screening. This will be a major breakthrough toward fabrication of larger scale organs. Studies have been done to construct perfusable blood vessel connecting capillaries cardiac tissue by a 3D cell sheet fabrication technology, in which endothelial cells within cardiac cells sheet sprouted and connected to the main blood vessel upon perfusion of growth factor-rich culture media [23] . Other studies have also shown that a prevascularized hepatic bud, when transplanted in vivo, can successfully anastomose to the main blood vessel and survive for a long period of time, carrying out its function [11] . All these highlights offer foreseeable potential for the hybrid bioprinting technique to have a similar nature-driven process upon perfusion. When the media are perfused through a continuous vascular network within the hybrid tissue, the biological signals as well as the media gradient along the perfusion direction within the media would guide endothelial cell reorganization, migration, and carry out of angiogenesis within the tissue strands, more importantly enable sprouting toward the media supply direction (Fig. 7) .
Newly generated capillaries within tissue strands are expected to create bridging with main vasculatures, so that media supplied through these newly formed capillaries would guarantee the survival of tissue strands for longer period of time. Prolonged media circulation within the newly generated vessel system would also accelerate the tissue maturation process by supplying sufficient growth factors, which drive tissue-specific cells to secrete ECM and further facilitate tissue strands fusion from all directions in 3D, producing a functional vascularized perfusable tissue. Later, the matured tissue could be used for drug testing by directly delivering different drugs via the perfusing system to evaluate tissue response. Moreover, bioprinted tissue could be implanted in vivo by anastomosing the main vasculature to the host to replace damaged or diseased tissues or organs.
Proof-of-Concept Study
In this section, we demonstrate a proof of concept of the tissue self-assembly around a 1.5 cm long smooth muscle vasculature. The vasculature was fabricated using the parameters given in Sec. 2.1.1, enabling media perfusion without any occlusion. It was longer than the cell aggregate strands (5 mm long) so it could hook up to the perfusion chamber. We kept the tissue construct in static culture first upon fabrication to keep it mechanically and structurally integrated until sufficient maturation was obtained. After 1 day in culture, fibroblast cell aggregate strands started fusing to each other. Later, perfect maturation was obtained in 7 days. In general, the duration depends on the cell type and the culture conditions (i.e., static, perfusion, etc.) used. We tried to pull the vasculature from the tissue and observed that the tissue attached to the vasculature completely (see Figs. 8(a) and 8(b) ). Crosssectional view in Fig. 8(c) demonstrates that tissue strands enclosed the vasculature and adhere to the smooth muscle matrix tightly. Therefore, tissue strands can be used for demonstrating large-scale hybrid tissue bioprinting concept.
Discussions
In this paper, scale-up hybrid tissue printing concept has been presented, which gives great promises with broad applications in basic biomedical research as well as clinical scenarios. However, challenges and limitations are still inevitable in every aspect of this process.
First of all, tissue strand fabrication is a biomaterial-free approach, which needs a great number of cells that usually exceeds the capability of the traditional cell culture and expanding setting in a short period of time. Thus, an advanced and accelerated cell culture techniques need to be designed to expedite cell expanding to meet the demand for large numbers of cells in a reducing culturing time. One way to fulfill this goal is to design 3D culture substrates or a cell culture vessel [24] ; also, special chemicals or small molecules can be integrated into cell culture media to accelerate cell proliferation without losing their phenotype in order to meet the required number of cells for tissue strand fabrication [25] .
Another critical issue is the usage of chemically crosslinked hydrogels for vasculature bioprinting. In order to generate a directly printed, mechanically strong vasculature, a higher concentration of hydrogel needs to be used. In that case, cells are largely entrapped individually within the hydrogel matrix with a relatively lower infiltration rate of cells. It also limits migration or proliferation of cells, which results in less cell-cell interaction, limits normal cell function, and results in less ECM deposition. In the future, other materials like collagen and elastin may also be integrated within a low concentration of chemically crosslinked hydrogel to supplement for mechanical strength as well as providing a more optimal condition for cell growth and function. Last but not least, the mechanical property of the printed vasculature needs further optimization, since tissue strands would generate great forces from all directions on the vasculature. Nanoscale materials such as electrospun protein fibers can be introduced within the vasculature wall to enhance its mechanical properties. Capillary sprouting from the macrovascular network to tissue strands also depends on the biological performance of the vasculatures as well as the applied perfusion setting. Therefore, a highly porous vasculature network is essential; it will enable endothelial cells to migrate and organize themselves based on the flow directions and applied growth factors to trigger them. Endothelial cells can be seeded during the bioprinting process or can be perfused and glued to the luminal surface of the vasculature during the perfusion process. Gluing endothelial cells is well established in the literature and currently used for decellularized organs [26] . Although this has been demonstrated in a few recent Nature papers [23, 27] using both artificial and natural vessels, more studies should be conducted to understand this phenomenon further to develop a well-established protocol.
One of the important issues after the hybrid bioprinting process is that the printed tissue construct cannot be directly connected to the perfusion unit while the tissue and the vasculature are not structurally integrated and cannot withstand perfusion. The media flow, under certain pressures ranging from 20 to 55 mmHg and flow rates from 30 to 50 ml/min for a biomimetic hemodynamically equivalent environment, can easily blow the whole construct. Therefore, the construct should be kept in static media culture and treated very gently during handling and media addition. Once sufficient mechanical coherency is obtained, the construct can be transferred to the perfusion unit for further fusion and maturation processes. In order to avoid any potential issues after the bioprinting process, the tissue construct can be directly printed into the perfusion chamber. The designed perfusion chamber should hold the construct precisely as a support structure until tissue fusion is achieved. Upon successful tissue fusion and maturation, the free-standing tissue can be easily used for different purposes, such as in vitro drug testing or transplantation to an animal model, particularly into a highly vascularized place in vivo.
Polymer-free bioprinting is one of the most exciting directions in tissue printing. It enables rapid fabrication of tissues and overcomes all the drawbacks associated with polymers, such as degradation and related toxic products, limited cell infiltration and encapsulation capability, poor cell migration and proliferation inside the polymer matrix, and less chance for vascularization. Despite the great advantages, mechanical properties are the major drawback, and careful investigation should be conducted to achieve acceptable mechanical rigidity before and after the bioprinting process. In general, culturing tissue strands for a longer period of time generates better mechanical properties because cells deposit more ECM, particularly elastin and collagen proteins; however, their fusion and adhesion capabilities decrease while maturation is completed during the tissue strand fabrication process. Thus, the cell needs to be guided biologically to deposit satisfactory collagen and elastin in a shorter period of time to provide mechanical strength; these are the major proteins in the connective tissue stromal of parenchymal organs. Better mechanical coherency also helps the operator to load the bio-ink easily without any challenges. In this regard, novel nozzle configurations should be developed, which enable the loading and printing of these strands with minimum structural damage, preserving their integrity.
Conclusions
This paper demonstrates a new approach in fabrication of living tissues and organs on a larger scale using 3D printing technology, where scale-up tissue printing can be performed in two major steps: (i) printing a continuous vasculature network in tandem with the rest of the multicellular vascularized tissue strands and (ii) biological maturation where tissue fusion and maturation occurs along with envisioned biologically driven capillary sprouting from the main vasculature steam. We have demonstrated the proof-of-concept of tissue self-assembly around a smaller-scale macrovasculature. Although the MABP can be used in developing larger-scale tissues with the proposed design strategy along with an associated toolpath plan for both arms, further research in both bioprinting technology and developmental biology needs to be conducted to biomimetically develop tissues for transplant and in vitro testing for various tissue types. For future work, we will expand our fabricated hybrid tissue models in 3D with more cell types cocultured into tissue strands and work on creating neovascularization and capillary sprouting within free-standing tissue systems.
